Price Alert

Telomir Pharmaceuticals I... (TELO)

NASDAQ: TELO · Real-Time Price · USD

1.18

-0.02 (-1.67%)

At close: Sep 03, 2025, 3:59 PM

1.14

-3.39%

Pre-market: Sep 04, 2025, 09:11 AM EDT

Telomir Pharmaceuticals Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-16.53M	-13.07M	-854.15K	-138.13K
Depreciation & Amortization	4.34M	n/a	n/a	n/a
Stock-Based Compensation	6.87M	n/a	n/a	n/a
Other Working Capital	-57.16K	-713	n/a	n/a
Other Non-Cash Items	130K	9.1M	-385.49K	-18.73K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	126.47K	113.84K	385.49K	18.73K
Operating Cash Flow	-5.07M	-3.86M	-468.66K	-119.4K
Capital Expenditures	n/a	-4	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a
Debt Repayment	-101K	3.12M	462.39K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-396.64K	-255.97K	7.69K	119.4K
Financial Cash Flow	6.34M	3.86M	470.08K	119.4K
Net Cash Flow	1.26M	-188	1.42K	n/a
Free Cash Flow	-5.07M	-3.86M	-468.66K	-119.4K